KIMBERLY PERDOMO: Open Payments
NPI 1861068827 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 77 payments from 21 companies in 2025. Trend: 2023 $398 · 2024 $866 · 2025 $1,211
Food & beverage: $1,195Education: $17
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $169 |
| Novo Nordisk Inc | 12 | $135 |
| Amgen Inc. | 6 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Vifor Pharma, Inc. | 5 | $81 |
| Calliditas Therapeutics US Inc. | 4 | $73 |
| SCPHARMACEUTICALS INC. | 4 | $72 |
| Lilly USA, LLC | 4 | $69 |
| OPKO Pharmaceuticals, LLC | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
Products named: Korlym, Ozempic, JARDIANCE, Kerendia, Veltassa, TARPEYO, FUROSCIX, REPATHA.
Industry payments across NJ — which companies pay providers there.
